Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$0.26.

  • Treace Medical Concepts' EPS (Basic) fell 400.0% to -$0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.8, marking a year-over-year increase of 1919.19%. This contributed to the annual value of -$0.9 for FY2024, which is 1090.87% down from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' EPS (Basic) is -$0.26, which was down 400.0% from -$0.28 recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' EPS (Basic) peaked at -$0.01 during Q4 2024, and registered a low of -$0.34 during Q2 2024.
  • Over the past 5 years, Treace Medical Concepts' median EPS (Basic) value was -$0.22 (recorded in 2022), while the average stood at -$0.19.
  • As far as peak fluctuations go, Treace Medical Concepts' EPS (Basic) crashed by 31063.05% in 2021, and later soared by 9049.01% in 2024.
  • Treace Medical Concepts' EPS (Basic) (Quarter) stood at -$0.14 in 2021, then surged by 48.8% to -$0.07 in 2022, then crashed by 49.71% to -$0.1 in 2023, then soared by 90.49% to -$0.01 in 2024, then plummeted by 2508.91% to -$0.26 in 2025.
  • Its EPS (Basic) stands at -$0.26 for Q3 2025, versus -$0.28 for Q2 2025 and -$0.25 for Q1 2025.